Moderna Inc. said on November 17 the company had applied with the U.S. Food and Drug Administration for authorization of the Covid-19 booster vaccine for all adults aged 18 and older.
Iterum Therapeutics will head back into the clinic to meet regulatory requirements to refile a New Drug Application for oral sulopenem, which has been developed to treat uncomplicated urinary tract infections.
Pfizer Inc. said on November 16 the company is seeking U.S. authorization of the experimental antiviral Covid-19 pill Paxlovid that cut the chance of hospitalization or death for adults at risk of severe disease by 89 percent in a clinical trial.
Following years of preparation, scientists from Brigham and Women’s Hospital are ready to start a clinical trial that will evaluate the use of an intranasal vaccine to prevent Alzheimer’s disease (AD).
Companies have recently posted major developments in the field of heart disease therapy, including the announcement by AstraZeneca and Moderna that their drug candidate for the treatment of patients with heart failure met the Phase IIA EPICCURE trial’s primary endpoint of safety and tolerability.
Scientists from the University of Virginia revealed the discovery of 17 total genes directly implicated in the development of obesity, an important breakthrough as the Covid-19 pandemic has escalated this persistent and often-overlooked crisis.
Pfizer Inc. said on Tuesday the company will allow generic manufacturers to supply its experimental antiviral Covid-19 pill to 95 low-income and middle-income countries through a licensing agreement with the international public health group Medicines Patent Pool (MPP).
Dr. Reddy’s Laboratories – one of a handful of Indian drug companies licensed to make a new Covid-19 pill developed by Merck – said on November 15 that the manufacturer was open to making a similar pill from Pfizer, thought to be even more effective.
As a class of drugs to treat high cholesterol, PCSK9 inhibitors have had trouble gaining tracking in the marketplace.
Cannabis Science and Technology is hosting the 2nd annual Hemp Science & Technology Virtual Symposium November 30-December 1, 2021.
